A new chiral stationary phase based on noscapine: Synthesis, enantioseparation, and docking study
- PMID: 35778873
- DOI: 10.1002/chir.23488
A new chiral stationary phase based on noscapine: Synthesis, enantioseparation, and docking study
Abstract
Noscapine is an isolated compound from the opium poppy, with distinctive chiral structure and chemistry, interacts with other compounds due to having multiple π-acceptors, hydrogen bond acceptors, and ionic sites. Therefore, it has promising applicability for the enantioselective separation of a wide range of polar, acidic, basic, and neutral compounds. A new noscapine derivative chiral stationary phase (ND-CSP) has been synthesized by consecutive N-demethylation, reduction, and N-propargylation of noscapine followed by attachment of a solid epoxy-functionalized silica bed through the 1,3-dipolar Huisgen cycloaddition. The noscapine derivative-based stationary phase provides a considerable surface coverage, which is greater than some commercial CSPs and can validate better enantioresolution performance. The major advantages inherent to this chiral selector are stability, reproducibility after more than 200 tests, and substantial loading capacity. The characterization by Fourier transform infrared (FTIR) spectroscopy and elemental analysis indicated successful functionalization of the silica surface. Chromatographic method conditions like flow rate and mobile phase composition for enantioseparation of various compounds such as warfarin, propranolol, mandelic acid, and a sulfanilamide derivative were optimized. Comparing the experimental results with docking data revealed a clear correlation between the calculated binding energy of ND-CSP and each enantiomer with the resolution of enantiomer peaks.
Keywords: alkaloid-based chiral selector; docking simulation; enantiomeric separation; mandelic acid; propranolol; warfarin.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Welch CJ. Chiral Chromatography in Support of Pharmaceutical Process Research. Prep Enantiosel Chromatogr. 2007;12:1-18. doi:10.1002/9780470988428.ch1
-
- Lucarini E, Trallori E, Tomassoni D, et al. Toxicological profile of the pain-relieving antioxidant compound thioctic acid in its racemic and enantiomeric forms. Antioxidants. 2020;9(8):1-16. doi:10.3390/antiox9080749
-
- Yue S, Kong Y, Shen Q, Cui Q, Chen Y, Zhao M. Assessing the Efficacy-Risk of the Widely Used Chiral Glufosinate: Switch from the Racemate to the Single Enantiomer? Environ Sci Technol Lett. 2020;7(3):143-148. doi:10.1021/acs.estlett.9b00789
-
- Calcaterra A, Acquarica ID. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds. J Pharm Biomed Anal. 2018;147:323-340. doi:10.1016/j.jpba.2017.07.008
-
- Zeng L, Yi Q, Liu Q, Tang K, van der Bruggen B. Development of a new method and device for chiral drug enrichment and enantioseparation: Multiple-phase extraction and in situ coupling of crystallization. Sep Purif Technol. 2021;257:117884. doi:10.1016/j.seppur.2020.117884
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
